FDA Inspection 694671 — Carter BloodCare

Carter BloodCare — FEI 3000717800

The FDA completed an inspection of Carter BloodCare on Oct 15, 2010 in Flower Mound, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 15, 2010
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Flower Mound, TX (United States)

Citations

IDCFRDescription
6721 CFR 606.65(e)Following manufacturer's instructions
928821 CFR 640.21(a)Eligibility of platelet donors
9821 CFR 606.100(c)Thorough investigations

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.